Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Level Biotechnology Inc. (3118) Income Statement

Level Biotechnology Inc. Income Statement

Last quarter (Q2 2026), Level Biotechnology Inc.'s total revenue was NT$162.35M, a decrease of 5.37% from the same quarter last year. In Q2, Level Biotechnology Inc.'s net income was NT$13.51M. See Level Biotechnology Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 736.59MNT$ 731.35MNT$ 660.61MNT$ 593.01MNT$ 677.28M
NT$ 244.31MNT$ 237.13MNT$ 219.54MNT$ 202.59MNT$ 232.50M
NT$ 160.76MNT$ 161.87MNT$ 151.99MNT$ 137.69MNT$ 153.54M
Depreciation and AmortizationNT$ 22.45MNT$ 21.21MNT$ 19.72MNT$ 19.50MNT$ 19.79M
NT$ 106.00MNT$ 102.62MNT$ 98.70MNT$ 93.00MNT$ 105.06M
NT$ 83.55MNT$ 75.26MNT$ 67.55MNT$ 64.90MNT$ 78.96M
NT$ 14.03MNT$ 5.81MNT$ 11.10MNT$ 8.25MNT$ 5.93M
NT$ 97.58MNT$ 81.13MNT$ 78.65MNT$ 73.16MNT$ 84.89M
NT$ 79.70MNT$ 64.81MNT$ 62.91MNT$ 58.47MNT$ 68.18M
Per Share Metrics
Basic EPSNT$ 2.46NT$ 1.99NT$ 1.94NT$ 1.80NT$ 2.10
Diluted EPSNT$ 2.44NT$ 1.99NT$ 1.93NT$ 1.79NT$ 2.09
Weighted Average Shares Outstanding32.45M32.45M32.43M32.45M32.45M
Weighted Average Shares Outstanding (Diluted)32.67M32.65M32.66M32.67M32.67M

Currency in TWD

Level Biotechnology Inc. Earnings and Revenue History

0300M600M900M5 %7.5 %10 %12.5 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin